11 Nov 2022 , 08:38 AM
Net profit of Supriya Lifescience declined 71.04% to Rs 16.86 crore in the quarter ended September 2022 as against Rs 58.22 crore during the previous quarter ended September 2021. Sales declined 24.21% to Rs 112.17 crore in the quarter ended September 2022 as against Rs 148.01 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 112.17 | 148.01 | -24 |
| OPM % | 25.46 | 52.77 | – |
| PBDT | 30.39 | 80.21 | -62 |
| PBT | 27.42 | 77.75 | -65 |
| NP | 16.86 | 58.22 | -71 |
Powered by Capital Market – Live News
Related Tags
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
